The AMA is holding the fourth webinar in its series, “COVID-19: What physicians need to know.”
AMA President Susan R. Bailey, MD, will host the webinar, and she will be joined by guest Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA). Dr. Marks will discuss the latest developments on the road to effective COVID-19 vaccines. Dr. Marks will do a deep dive into the Emergency Use Authorization (EUA) process, specifically explaining how the timeline has been shortened from a matter of years to a matter of months. Physicians will learn the similarities and differences between routine vaccine development and the EUA process and understand how accelerated approval is being arrived at safely.
Registration is limited to physicians, residents, medical students and Federation staff.
